Broad substrate specificity ATP-binding cassette transporter ABCG2
Details
- Name
- Broad substrate specificity ATP-binding cassette transporter ABCG2
- Kind
- protein
- Synonyms
- 7.6.2.2
- ABCP
- ATP-binding cassette sub-family G member 2
- BCRP
- BCRP1
- Breast cancer resistance protein
- CDw338
- Mitoxantrone resistance-associated protein
- MXR
- Placenta-specific ATP-binding cassette transporter
- Urate exporter
- Gene Name
- ABCG2
- UniProtKB Entry
- Q9UNQ0Swiss-Prot
- Organism
- Humans
- NCBI Taxonomy ID
- 9606
- Amino acid sequence
>lcl|BSEQ0002125|Broad substrate specificity ATP-binding cassette transporter ABCG2 MSSSNVEVFIPVSQGNTNGFPATASNDLKAFTEGAVLSFHNICYRVKLKSGFLPCRKPVE KEILSNINGIMKPGLNAILGPTGGGKSSLLDVLAARKDPSGLSGDVLINGAPRPANFKCN SGYVVQDDVVMGTLTVRENLQFSAALRLATTMTNHEKNERINRVIQELGLDKVADSKVGT QFIRGVSGGERKRTSIGMELITDPSILFLDEPTTGLDSSTANAVLLLLKRMSKQGRTIIF SIHQPRYSIFKLFDSLTLLASGRLMFHGPAQEALGYFESAGYHCEAYNNPADFFLDIING DSTAVALNREEDFKATEIIEPSKQDKPLIEKLAEIYVNSSFYKETKAELHQLSGGEKKKK ITVFKEISYTTSFCHQLRWVSKRSFKNLLGNPQASIAQIIVTVVLGLVIGAIYFGLKNDS TGIQNRAGVLFFLTTNQCFSSVSAVELFVVEKKLFIHEYISGYYRVSSYFLGKLLSDLLP MRMLPSIIFTCIVYFMLGLKPKADAFFVMMFTLMMVAYSASSMALAIAAGQSVVSVATLL MTICFVFMMIFSGLLVNLTTIASWLSWLQYFSIPRYGFTALQHNEFLGQNFCPGLNATGN NPCNYATCTGEEYLVKQGIDLSPWGLWKNHVALACMIVIFLTIAYLKLLFLKKYS
- Number of residues
- 655
- Molecular Weight
- 72313.47
- Theoretical pI
- 8.9
- GO Classification
- FunctionsATP binding / protein homodimerization activityProcessestransmembrane transport / urate metabolic processComponentsmitochondrial membrane / plasma membrane
- General Function
- Broad substrate specificity ATP-dependent transporter of the ATP-binding cassette (ABC) family that actively extrudes a wide variety of physiological compounds, dietary toxins and xenobiotics from cells (PubMed:11306452, PubMed:12958161, PubMed:19506252, PubMed:20705604, PubMed:28554189, PubMed:30405239, PubMed:31003562). Involved in porphyrin homeostasis, mediating the export of protoporphyrin IX (PPIX) from both mitochondria to cytosol and cytosol to extracellular space, it also functions in the cellular export of heme (PubMed:20705604, PubMed:23189181). Also mediates the efflux of sphingosine-1-P from cells (PubMed:20110355). Acts as a urate exporter functioning in both renal and extrarenal urate excretion (PubMed:19506252, PubMed:20368174, PubMed:22132962, PubMed:31003562, PubMed:36749388). In kidney, it also functions as a physiological exporter of the uremic toxin indoxyl sulfate (By similarity). Also involved in the excretion of steroids like estrone 3-sulfate/E1S, 3beta-sulfooxy-androst-5-en-17-one/DHEAS, and other sulfate conjugates (PubMed:12682043, PubMed:28554189, PubMed:30405239). Mediates the secretion of the riboflavin and biotin vitamins into milk (By similarity). Extrudes pheophorbide a, a phototoxic porphyrin catabolite of chlorophyll, reducing its bioavailability (By similarity). Plays an important role in the exclusion of xenobiotics from the brain (Probable). It confers to cells a resistance to multiple drugs and other xenobiotics including mitoxantrone, pheophorbide, camptothecin, methotrexate, azidothymidine, and the anthracyclines daunorubicin and doxorubicin, through the control of their efflux (PubMed:11306452, PubMed:12477054, PubMed:15670731, PubMed:18056989, PubMed:31254042). In placenta, it limits the penetration of drugs from the maternal plasma into the fetus (By similarity). May play a role in early stem cell self-renewal by blocking differentiation (By similarity)
- Specific Function
- Abc-type xenobiotic transporter activity
- Pfam Domain Function
- Signal Regions
- Not Available
- Transmembrane Regions
- 396-416 429-449 478-498 507-527 536-556 631-651
- Cellular Location
- Cell membrane
- Gene sequence
>lcl|BSEQ0016303|ATP-binding cassette sub-family G member 2 (ABCG2) ATGTCTTCCAGTAATGTCGAAGTTTTTATCCCAGTGTCACAAGGAAACACCAATGGCTTC CCCGCGACAGCTTCCAATGACCTGAAGGCATTTACTGAAGGAGCTGTGTTAAGTTTTCAT AACATCTGCTATCGAGTAAAACTGAAGAGTGGCTTTCTACCTTGTCGAAAACCAGTTGAG AAAGAAATATTATCGAATATCAATGGGATCATGAAACCTGGTCTCAACGCCATCCTGGGA CCCACAGGTGGAGGCAAATCTTCGTTATTAGATGTCTTAGCTGCAAGGAAAGATCCAAGT GGATTATCTGGAGATGTTCTGATAAATGGAGCACCGCGACCTGCCAATTTCAAATGTAAT TCAGGTTACGTGGTACAAGATGATGTTGTGATGGGCACTCTGACGGTGAGAGAAAACTTA CAGTTCTCAGCAGCTCTTCGGCTTGCAACAACTATGACGAATCATGAAAAAAACGAACGG ATTAACAGGGTCATTCAAGAGTTAGGTCTGGATAAAGTGGCAGACTCCAAGGTTGGAACT CAGTTTATCCGTGGTGTGTCTGGAGGAGAAAGAAAAAGGACTAGTATAGGAATGGAGCTT ATCACTGATCCTTCCATCTTGTTCTTGGATGAGCCTACAACTGGCTTAGACTCAAGCACA GCAAATGCTGTCCTTTTGCTCCTGAAAAGGATGTCTAAGCAGGGACGAACAATCATCTTC TCCATTCATCAGCCTCGATATTCCATCTTCAAGTTGTTTGATAGCCTCACCTTATTGGCC TCAGGAAGACTTATGTTCCACGGGCCTGCTCAGGAGGCCTTGGGATACTTTGAATCAGCT GGTTATCACTGTGAGGCCTATAATAACCCTGCAGACTTCTTCTTGGACATCATTAATGGA GATTCCACTGCTGTGGCATTAAACAGAGAAGAAGACTTTAAAGCCACAGAGATCATAGAG CCTTCCAAGCAGGATAAGCCACTCATAGAAAAATTAGCGGAGATTTATGTCAACTCCTCC TTCTACAAAGAGACAAAAGCTGAATTACATCAACTTTCCGGGGGTGAGAAGAAGAAGAAG ATCACAGTCTTCAAGGAGATCAGCTACACCACCTCCTTCTGTCATCAACTCAGATGGGTT TCCAAGCGTTCATTCAAAAACTTGCTGGGTAATCCCCAGGCCTCTATAGCTCAGATCATT GTCACAGTCGTACTGGGACTGGTTATAGGTGCCATTTACTTTGGGCTAAAAAATGATTCT ACTGGAATCCAGAACAGAGCTGGGGTTCTCTTCTTCCTGACGACCAACCAGTGTTTCAGC AGTGTTTCAGCCGTGGAACTCTTTGTGGTAGAGAAGAAGCTCTTCATACATGAATACATC AGCGGATACTACAGAGTGTCATCTTATTTCCTTGGAAAACTGTTATCTGATTTATTACCC ATGAGGATGTTACCAAGTATTATATTTACCTGTATAGTGTACTTCATGTTAGGATTGAAG CCAAAGGCAGATGCCTTCTTCGTTATGATGTTTACCCTTATGATGGTGGCTTATTCAGCC AGTTCCATGGCACTGGCCATAGCAGCAGGTCAGAGTGTGGTTTCTGTAGCAACACTTCTC ATGACCATCTGTTTTGTGTTTATGATGGTCTGTTGGTCAATCTCACAACCATTGCATCTT GGCTGTCATGGCTTCAGTACTTCAGCATTCCACGATATGGATTTACGGCTTTGCAGCATA ATGAATTTTTGGGACAAAACTTCTGCCCAGGACTCAATGCAACAGGAAACAATCCTTGTA ACTATGCAACATGTACTGGCGAAGAATATTTGGTAA
- Chromosome Location
- 4
- Locus
- 4q22.1
- External Identifiers
Resource Link UniProtKB ID Q9UNQ0 UniProtKB Entry Name ABCG2_HUMAN GenBank Protein ID 4185796 GenBank Gene ID AF103796 GeneCard ID ABCG2 GenAtlas ID ABCG2 HGNC ID HGNC:74 PDB ID(s) 5NJ3, 5NJG, 6ETI, 6FEQ, 6FFC, 6HBU, 6HCO, 6HIJ, 6HZM, 6VXF, 6VXH, 6VXI, 6VXJ, 7NEQ, 7NEZ, 7NFD, 7OJ8, 7OJH, 7OJI, 8BHT, 8BI0, 8P7W, 8P8A, 8P8J, 8U2C KEGG ID hsa:9429 IUPHAR/Guide To Pharmacology ID 792 NCBI Gene ID 9429 - General References
- Allikmets R, Schriml LM, Hutchinson A, Romano-Spica V, Dean M: A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res. 1998 Dec 1;58(23):5337-9. [Article]
- Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK, Ross DD: A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15665-70. [Article]
- Komatani H, Kotani H, Hara Y, Nakagawa R, Matsumoto M, Arakawa H, Nishimura S: Identification of breast cancer resistant protein/mitoxantrone resistance/placenta-specific, ATP-binding cassette transporter as a transporter of NB-506 and J-107088, topoisomerase I inhibitors with an indolocarbazole structure. Cancer Res. 2001 Apr 1;61(7):2827-32. [Article]
- Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M, Nakauchi H, Sorrentino BP: The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med. 2001 Sep;7(9):1028-34. [Article]
- Zhang W, Mojsilovic-Petrovic J, Andrade MF, Zhang H, Ball M, Stanimirovic DB: The expression and functional characterization of ABCG2 in brain endothelial cells and vessels. FASEB J. 2003 Nov;17(14):2085-7. Epub 2003 Sep 4. [Article]
- Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article]
- Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31. [Article]
- Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article]
- Miyake K, Mickley L, Litman T, Zhan Z, Robey R, Cristensen B, Brangi M, Greenberger L, Dean M, Fojo T, Bates SE: Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res. 1999 Jan 1;59(1):8-13. [Article]
- Schmitz G, Langmann T, Heimerl S: Role of ABCG1 and other ABCG family members in lipid metabolism. J Lipid Res. 2001 Oct;42(10):1513-20. [Article]
- Xu J, Liu Y, Yang Y, Bates S, Zhang JT: Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2. J Biol Chem. 2004 May 7;279(19):19781-9. Epub 2004 Mar 4. [Article]
- Diop NK, Hrycyna CA: N-Linked glycosylation of the human ABC transporter ABCG2 on asparagine 596 is not essential for expression, transport activity, or trafficking to the plasma membrane. Biochemistry. 2005 Apr 12;44(14):5420-9. [Article]
- Ozvegy-Laczka C, Koblos G, Sarkadi B, Varadi A: Single amino acid (482) variants of the ABCG2 multidrug transporter: major differences in transport capacity and substrate recognition. Biochim Biophys Acta. 2005 Feb 1;1668(1):53-63. [Article]
- Henriksen U, Gether U, Litman T: Effect of Walker A mutation (K86M) on oligomerization and surface targeting of the multidrug resistance transporter ABCG2. J Cell Sci. 2005 Apr 1;118(Pt 7):1417-26. Epub 2005 Mar 15. [Article]
- Wakabayashi K, Nakagawa H, Tamura A, Koshiba S, Hoshijima K, Komada M, Ishikawa T: Intramolecular disulfide bond is a critical check point determining degradative fates of ATP-binding cassette (ABC) transporter ABCG2 protein. J Biol Chem. 2007 Sep 21;282(38):27841-6. Epub 2007 Aug 8. [Article]
- Dehghan A, Kottgen A, Yang Q, Hwang SJ, Kao WL, Rivadeneira F, Boerwinkle E, Levy D, Hofman A, Astor BC, Benjamin EJ, van Duijn CM, Witteman JC, Coresh J, Fox CS: Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet. 2008 Dec 6;372(9654):1953-61. doi: 10.1016/S0140-6736(08)61343-4. Epub 2008 Oct 1. [Article]
- Woodward OM, Kottgen A, Coresh J, Boerwinkle E, Guggino WB, Kottgen M: Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci U S A. 2009 Jun 23;106(25):10338-42. doi: 10.1073/pnas.0901249106. Epub 2009 Jun 8. [Article]
- Matsuo H, Takada T, Ichida K, Nakamura T, Nakayama A, Ikebuchi Y, Ito K, Kusanagi Y, Chiba T, Tadokoro S, Takada Y, Oikawa Y, Inoue H, Suzuki K, Okada R, Nishiyama J, Domoto H, Watanabe S, Fujita M, Morimoto Y, Naito M, Nishio K, Hishida A, Wakai K, Asai Y, Niwa K, Kamakura K, Nonoyama S, Sakurai Y, Hosoya T, Kanai Y, Suzuki H, Hamajima N, Shinomiya N: Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Sci Transl Med. 2009 Nov 4;1(5):5ra11. doi: 10.1126/scitranslmed.3000237. [Article]
- Desuzinges-Mandon E, Arnaud O, Martinez L, Huche F, Di Pietro A, Falson P: ABCG2 transports and transfers heme to albumin through its large extracellular loop. J Biol Chem. 2010 Oct 22;285(43):33123-33. doi: 10.1074/jbc.M110.139170. Epub 2010 Aug 12. [Article]
- Nakayama A, Matsuo H, Takada T, Ichida K, Nakamura T, Ikebuchi Y, Ito K, Hosoya T, Kanai Y, Suzuki H, Shinomiya N: ABCG2 is a high-capacity urate transporter and its genetic impairment increases serum uric acid levels in humans. Nucleosides Nucleotides Nucleic Acids. 2011 Dec;30(12):1091-7. doi: 10.1080/15257770.2011.633953. [Article]
- Mo W, Zhang JT: Human ABCG2: structure, function, and its role in multidrug resistance. Int J Biochem Mol Biol. 2012;3(1):1-27. Epub 2011 Mar 30. [Article]
- Zelinski T, Coghlan G, Liu XQ, Reid ME: ABCG2 null alleles define the Jr(a-) blood group phenotype. Nat Genet. 2012 Jan 15;44(2):131-2. doi: 10.1038/ng.1075. [Article]
- Saison C, Helias V, Ballif BA, Peyrard T, Puy H, Miyazaki T, Perrot S, Vayssier-Taussat M, Waldner M, Le Pennec PY, Cartron JP, Arnaud L: Null alleles of ABCG2 encoding the breast cancer resistance protein define the new blood group system Junior. Nat Genet. 2012 Jan 15;44(2):174-7. doi: 10.1038/ng.1070. [Article]
- Kobuchi H, Moriya K, Ogino T, Fujita H, Inoue K, Shuin T, Yasuda T, Utsumi K, Utsumi T: Mitochondrial localization of ABC transporter ABCG2 and its function in 5-aminolevulinic acid-mediated protoporphyrin IX accumulation. PLoS One. 2012;7(11):e50082. doi: 10.1371/journal.pone.0050082. Epub 2012 Nov 26. [Article]
- Iida A, Saito S, Sekine A, Mishima C, Kitamura Y, Kondo K, Harigae S, Osawa S, Nakamura Y: Catalog of 605 single-nucleotide polymorphisms (SNPs) among 13 genes encoding human ATP-binding cassette transporters: ABCA4, ABCA7, ABCA8, ABCD1, ABCD3, ABCD4, ABCE1, ABCF1, ABCG1, ABCG2, ABCG4, ABCG5, and ABCG8. J Hum Genet. 2002;47(6):285-310. [Article]
- Itoda M, Saito Y, Shirao K, Minami H, Ohtsu A, Yoshida T, Saijo N, Suzuki H, Sugiyama Y, Ozawa S, Sawada J: Eight novel single nucleotide polymorphisms in ABCG2/BCRP in Japanese cancer patients administered irinotacan. Drug Metab Pharmacokinet. 2003;18(3):212-7. [Article]
- Zamber CP, Lamba JK, Yasuda K, Farnum J, Thummel K, Schuetz JD, Schuetz EG: Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine. Pharmacogenetics. 2003 Jan;13(1):19-28. [Article]
- Morisaki K, Robey RW, Ozvegy-Laczka C, Honjo Y, Polgar O, Steadman K, Sarkadi B, Bates SE: Single nucleotide polymorphisms modify the transporter activity of ABCG2. Cancer Chemother Pharmacol. 2005 Aug;56(2):161-72. Epub 2005 Apr 19. [Article]
- Maekawa K, Itoda M, Sai K, Saito Y, Kaniwa N, Shirao K, Hamaguchi T, Kunitoh H, Yamamoto N, Tamura T, Minami H, Kubota K, Ohtsu A, Yoshida T, Saijo N, Kamatani N, Ozawa S, Sawada J: Genetic variation and haplotype structure of the ABC transporter gene ABCG2 in a Japanese population. Drug Metab Pharmacokinet. 2006 Apr;21(2):109-21. [Article]
Associated Data
- Drug Relations
Drug Drug group Pharmacological action? Type Actions Details Biricodar investigational unknown target Details Gefitinib approved, investigational unknown transporter substrateinhibitor Details Quercetin experimental, investigational unknown transporter inhibitor Details Naringenin experimental unknown transporter inhibitor Details Topotecan approved, investigational unknown transporter substrate Details Novobiocin approved, investigational, vet_approved, withdrawn unknown transporter inhibitor Details Estrone approved unknown transporter inhibitor Details Saquinavir approved, investigational unknown transporter inhibitor Details Omeprazole approved, investigational, vet_approved unknown transporter inhibitor Details Hesperetin experimental unknown transporter inhibitor Details Genistein investigational unknown transporter inhibitor Details Nelfinavir approved no transporter inhibitor Details Glyburide approved unknown transporter substrate Details Diethylstilbestrol approved, investigational, withdrawn unknown transporter inhibitor Details Ritonavir approved, investigational unknown transporter inhibitor Details Pravastatin approved no transporter substrate Details Doxorubicin approved, investigational unknown transporter substrate Details Pantoprazole approved unknown transporter substrateinhibitor Details Cyclosporine approved, investigational, vet_approved unknown transporter inhibitor Details Taurocholic acid approved, experimental unknown transporter inhibitor Details Imatinib approved no transporter substrateinhibitor Details Estradiol approved, investigational, vet_approved unknown transporter inhibitor Details Mitoxantrone approved, investigational unknown transporter substrate Details Daidzin experimental unknown transporter inhibitor Details Sorafenib approved, investigational unknown transporter substrateinhibitor Details Sunitinib approved, investigational unknown transporter inhibitor Details Dronabinol approved, illicit no transporter inhibitor Details Buprenorphine approved, illicit, investigational, vet_approved unknown transporter inhibitor Details Sulfasalazine approved no transporter substrateinhibitor Details Telmisartan approved, investigational unknown transporter inhibitor Details Dexamethasone approved, investigational, vet_approved unknown transporter inhibitor Details Dasatinib approved, investigational unknown transporter substrateinhibitor Details Prazosin approved unknown transporter substrate Details Lansoprazole approved, investigational unknown transporter inhibitor Details Rabeprazole approved, investigational unknown transporter inhibitor Details Elacridar investigational unknown transporter inhibitor Details Nilotinib approved, investigational unknown transporter substrateinhibitor Details Erlotinib approved, investigational unknown transporter inhibitor Details Vandetanib approved unknown transporter inhibitor Details Lamivudine approved, investigational unknown transporter substrate Details Irinotecan approved, investigational unknown transporter substrate Details Etoposide approved unknown transporter substrate Details Dactinomycin approved, investigational unknown transporter substrate Details Conjugated estrogens approved unknown transporter substrate Details Cerivastatin approved, withdrawn unknown transporter substrate Details Testosterone approved, investigational unknown transporter substrate Details Tamoxifen approved unknown transporter substrate Details Sumatriptan approved, investigational unknown transporter substrate Details Daunorubicin approved unknown transporter substrate Details Cholesterol approved, investigational unknown transporter inducer Details Methotrexate approved unknown transporter substrate Details Folic acid approved, nutraceutical, vet_approved unknown transporter substrate Details Alvocidib experimental, investigational unknown transporter substrate Details Vincristine approved, investigational unknown transporter substrate Details Teniposide approved unknown transporter substrate Details Nitrofurantoin approved, vet_approved unknown transporter substrate Details Ivermectin approved, investigational, vet_approved unknown transporter substrate Details Camptothecin experimental unknown transporter substrate Details Riluzole approved, investigational unknown transporter substrate Details Cladribine approved, investigational unknown transporter substrate Details Clofarabine approved, investigational unknown transporter substrate Details Oxaliplatin approved, investigational no transporter substrate Details Cabazitaxel approved unknown transporter inhibitor Details Pitavastatin approved unknown transporter substrate Details Pazopanib approved unknown transporter substrate Details Rilpivirine approved unknown transporter inhibitor Details Teriflunomide approved unknown transporter substrateinhibitor Details Leflunomide approved, investigational unknown transporter substrate Details Vemurafenib approved unknown transporter substrateinhibitor Details Apixaban approved unknown transporter substrate Details Vismodegib approved, investigational unknown transporter inhibitor Details Regorafenib approved unknown transporter inhibitor Details Ponatinib approved, investigational unknown transporter substrateinhibitor Details Ezetimibe approved unknown transporter substrate Details Dabrafenib approved, investigational no transporter substrateinhibitor Details Zafirlukast approved, investigational unknown transporter antagonist Details Venlafaxine approved unknown transporter inducer Details Zidovudine approved unknown transporter substrate Details Afatinib approved unknown transporter substrateinhibitor Details Fluorouracil approved unknown transporter substrate Details Mycophenolate mofetil approved, investigational unknown transporter substrate Details Cisplatin approved unknown transporter substrate Details Carboplatin approved unknown transporter substrate Details Rosuvastatin approved unknown transporter substrate Details Docetaxel approved, investigational unknown transporter substrate Details Sofosbuvir approved no transporter substrate Details Lenvatinib approved, investigational no transporter substrate Details Idelalisib approved no transporter substrate Details Cobicistat approved unknown transporter inhibitor Details Rolapitant approved, investigational no transporter inhibitor Details Daclatasvir approved, investigational unknown transporter inhibitor Details Cobimetinib approved, investigational no transporter weak inhibitor Details Osimertinib approved no transporter substrate Details Alectinib approved, investigational no transporter inhibitor Details Riociguat approved no transporter substrate Details Dasabuvir approved unknown transporter inhibitor Details Safinamide approved, investigational unknown transporter inhibitor Details Velpatasvir approved, investigational no transporter substrateinhibitor Details Simeprevir approved unknown transporter substrateinhibitor Details Ledipasvir approved no transporter transporter Details Ombitasvir approved, investigational no transporter substrate Details Delafloxacin approved, investigational no transporter substrate Details Topiroxostat experimental unknown transporter inhibitor Details Voxilaprevir approved, investigational no transporter substrateinhibitor Details Enasidenib approved, investigational unknown transporter substrateinhibitor Details Pibrentasvir approved, investigational unknown transporter substrateinhibitor Details Glecaprevir approved, investigational unknown transporter substrateinhibitor Details Copanlisib approved, investigational unknown transporter substrate Details Abemaciclib approved, investigational unknown transporter substrateinhibitor Details Letermovir approved, investigational no transporter inhibitor Details Brigatinib approved, investigational no transporter substrateinhibitor Details Dolutegravir approved no transporter substrate Details Rucaparib approved, investigational no transporter substrateinhibitor Details Baricitinib approved, investigational unknown transporter substrateinhibitor Details Cannabidiol approved, investigational unknown transporter inhibitor Details Ertugliflozin approved, investigational unknown transporter substrate Details Testosterone cypionate approved unknown transporter substrate Details Testosterone enanthate approved unknown transporter substrate Details Testosterone undecanoate approved, investigational unknown transporter substrate Details Estradiol acetate approved, investigational, vet_approved unknown transporter inhibitor Details Estradiol benzoate approved, investigational, vet_approved unknown transporter inhibitor Details Estradiol cypionate approved, investigational, vet_approved unknown transporter inhibitor Details Estradiol dienanthate approved, investigational, vet_approved unknown transporter inhibitor Details Estradiol valerate approved, investigational, vet_approved unknown transporter inhibitor Details Apalutamide approved, investigational unknown transporter inducer Details Isavuconazole approved, investigational unknown transporter inhibitor Details Nabiximols investigational unknown transporter inhibitor Details Medical Cannabis experimental, investigational unknown transporter inhibitor Details Fostamatinib approved, investigational no transporter inhibitor Details Paritaprevir approved, investigational unknown transporter inhibitor Details Hydrocortisone aceponate experimental, vet_approved unknown transporter Details Hydrocortisone acetate approved, vet_approved unknown transporter Details Hydrocortisone butyrate approved, vet_approved unknown transporter Details Hydrocortisone cypionate approved, investigational, vet_approved unknown transporter Details Hydrocortisone phosphate approved, vet_approved unknown transporter Details Hydrocortisone probutate approved, vet_approved unknown transporter Details Hydrocortisone valerate approved, vet_approved unknown transporter Details Dovitinib investigational unknown transporter inhibitorinducer Details Lusutrombopag approved, investigational unknown transporter substrate Details Eltrombopag approved unknown transporter inhibitor Details Progesterone approved, vet_approved unknown transporter inhibitorinducer Details Fusidic acid approved, investigational unknown transporter inhibitor Details Duvelisib approved, investigational no transporter substrate Details Talazoparib approved, investigational unknown transporter substrate Details Dacomitinib approved, investigational no transporter substrateinhibitor Details Venetoclax approved, investigational unknown transporter inhibitor Details Revefenacin approved, investigational no transporter substrate Details Gilteritinib approved, investigational no transporter inhibitor Details Rivaroxaban approved unknown transporter substrate Details Fimasartan investigational unknown transporter substrate Details Glasdegib approved, investigational no transporter substrateinhibitor Details Olaparib approved no transporter inhibitor Details Allopurinol approved unknown transporter substrate Details Palbociclib approved, investigational no transporter substrateinhibitor Details Canagliflozin approved unknown transporter Details Tegaserod approved, investigational, withdrawn unknown transporter substrate Details Tenofovir alafenamide approved no transporter substrate Details Raloxifene approved, investigational unknown transporter substrate Details Alpelisib approved, investigational unknown transporter substrate Details Beclomethasone dipropionate approved, investigational unknown transporter inhibitor Details Celecoxib approved, investigational unknown transporter substrate Details Donepezil approved unknown transporter substrate Details Fedratinib approved, investigational unknown transporter inhibitor Details Istradefylline approved, investigational unknown transporter inhibitor Details Nintedanib approved unknown transporter Details Caffeine approved unknown transporter inhibitor Details Lasmiditan approved, investigational unknown transporter inhibitor Details Trastuzumab deruxtecan approved, investigational unknown transporter substrate Details Darolutamide approved, investigational unknown transporter substrateinhibitor Details Upadacitinib approved, investigational no transporter substrateinhibitor Details Ubrogepant approved, investigational unknown transporter substrate Details Avapritinib approved, investigational unknown transporter inhibitormodulator Details Tafamidis approved, investigational unknown transporter inhibitor Details Tazemetostat approved, investigational unknown transporter substrate Details Larotrectinib approved, investigational no transporter substrate Details Tezacaftor approved, investigational no transporter substrateinhibitor Details Rimegepant approved, investigational unknown transporter substrate Details Ozanimod approved, investigational unknown transporter substrate Details Prasterone approved, investigational, nutraceutical unknown transporter substrate Details Selumetinib approved, investigational unknown transporter substrate Details Tucatinib approved, investigational unknown transporter substrate Details Pemigatinib approved, investigational no transporter substrate Details Capmatinib approved, investigational unknown transporter inhibitor Details Pralatrexate approved, investigational no transporter substrate Details Selpercatinib approved, investigational unknown transporter substrateinhibitor Details Ripretinib approved unknown transporter substrateinhibitor Details Clofazimine approved, investigational unknown transporter inhibitor Details Empagliflozin approved unknown transporter substrate Details Artesunate approved, investigational unknown transporter substrate Details Dexamethasone acetate approved, investigational, vet_approved unknown transporter inhibitor Details Fostemsavir approved, investigational unknown transporter substrateinhibitor Details Risdiplam approved, investigational unknown transporter substrate Details Nifurtimox approved, investigational unknown transporter substrate Details Pralsetinib approved, investigational no transporter substrateinhibitor Details Lonafarnib approved, investigational no transporter inhibitor Details Berotralstat approved unknown transporter substrate Details Relugolix approved, investigational unknown transporter inhibitor Details Opicapone approved, investigational no transporter substrate Details Vericiguat approved, investigational unknown transporter substrate Details Cabotegravir approved, investigational unknown transporter substrate Details Tepotinib approved, investigational no transporter inhibitor Details Trilaciclib approved, investigational unknown transporter substrate Details Sulpiride approved, investigational unknown transporter substrate Details Temozolomide approved, investigational no transporter substrate Details Avanafil approved unknown transporter inhibitor Details Febuxostat approved no transporter inhibitor Details Tivozanib approved, investigational no transporter inhibitor Details Amisulpride approved, investigational no transporter substrate Details Sotorasib approved, investigational unknown transporter inhibitor Details Infigratinib approved, investigational no transporter substrateinhibitor Details Brincidofovir approved, investigational no transporter inhibitor Details Belumosudil approved, investigational no transporter inhibitor Details Mobocertinib approved, investigational unknown transporter inhibitor Details Atogepant approved, investigational no transporter substrate Details Asciminib approved, investigational no transporter substrateinhibitor Details Maribavir approved, investigational no transporter inhibitor Details Sotagliflozin approved, investigational no transporter inhibitor Details Roxadustat approved, investigational unknown transporter inhibitor Details Cannabinol experimental, investigational unknown transporter inhibitor Details Pacritinib approved, investigational no transporter inhibitor Details Oteseconazole approved, investigational no transporter inhibitor Details Azvudine investigational unknown target regulator Details Tecovirimat approved, investigational unknown transporter inhibitor Details Stiripentol approved unknown transporter inhibitor Details Baloxavir marboxil approved, investigational unknown transporter inhibitor Details Deucravacitinib approved, investigational unknown transporter substrateinhibitor Details Telotristat ethyl approved, investigational no carrier binder Details Futibatinib approved, investigational no transporter substrate Details Linzagolix approved no transporter substrate Details Niraparib approved, investigational no transporter substrateinhibitor Details Pemetrexed approved, investigational no transporter Details Olutasidenib approved, investigational no transporter inhibitor Details Pirtobrutinib approved, investigational unknown transporter substrateinhibitor Details Elacestrant approved, investigational unknown transporter inhibitor Details Daprodustat approved, investigational no transporter substrate Details Sparsentan approved, investigational unknown transporter substrateinhibitor Details Leniolisib approved, investigational no transporter substrateinhibitor Details Aripiprazole approved, investigational unknown transporter Details Vadadustat approved, investigational unknown transporter inhibitor Details Quizartinib approved, investigational no transporter inhibitor Details Palovarotene approved, investigational no transporter inhibitor Details Momelotinib approved, investigational unknown transporter substrateinhibitor Details Encorafenib approved, investigational no transporter inhibitor Details Gefapixant approved, investigational no transporter substrate Details Binimetinib approved, investigational no transporter substrate Details Capivasertib approved, investigational no transporter inhibitor Details Repotrectinib approved, investigational no transporter inhibitor Details Isavuconazonium approved, investigational unknown transporter inhibitor Details Avatrombopag approved, investigational no transporter inhibitor Details Itraconazole approved, investigational unknown transporter inhibitor Details Aprocitentan approved, investigational no transporter substrateinhibitor Details Resmetirom approved, investigational unknown transporter substrateinhibitor Details Danicopan approved, investigational no transporter inhibitor Details Tovorafenib approved, investigational unknown transporter inhibitor Details Elafibranor approved, investigational unknown transporter substrateinhibitor Details Ensifentrine approved, investigational unknown transporter substrate Details Deuruxolitinib investigational unknown transporter substrateinhibitor Details Vorasidenib approved, investigational unknown transporter inhibitor Details Seladelpar approved, investigational unknown transporter substrate Details Sulfasalazine approved yes target inhibitor Details Lazertinib approved, investigational unknown transporter inhibitor Details